The QualityStocks Daily Friday, March 1st, 2024

Today's Top 3 Investment Newsletters

QualityStocks(MTC) $2.5600 +96.92%

MarketClub Analysis(ADIL) $3.2600 +59.80%

360 Wall Street(REAL) $2.7600 +55.93%

The QualityStocks Daily Stock List


StreetInsider, QualityStocks, MarketClub Analysis, StockMarketWatch, TradersPro, Stockhouse, FreeRealTime and BUYINS.NET reported earlier on MMTec (MTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MMTec Inc. (NASDAQ: MTC) is a firm that is engaged in asset management services on various platforms. The firm has its headquarters in Beijing in the People’s Republic of China and was founded in 2015.

The firm provides solutions in securities settlements, market transactions and internet-based technology services to brokerage firms, mutual and hedge funds, proprietary trading groups and registered investment advisors worldwide. MMTec’s operating segments are MM Global and Gujia. The firm generates the majority of its revenue from the Gujia segment, which provides investor relations management and market data services to consumers in China.

MMTec Inc. is mainly involved in offering complete suite trading solutions, which include settlement and trading, distribution, custody and fund creation services, all of which assist financial institutions in boosting their integration into markets abroad. It also allows its consumers to select modular functionalities and white label its trading interface.

The firm’s platforms include the quantitative investment transaction platform, ETN counter business system, institutional and personal integrated account management systems, PC transaction client systems for Web, Android, PC and Apple IOS, personal mobile trading client system and PTN private fund investment management systems, which support requisition management, multi-account management, liquidation, fund valuation, risk management and quantitative trading access.

MMTec Inc. is near the top firms in its industry group, ranking at 74 in the Software Application Industry with its involvement in cryptocurrency moving the company higher up. Companies involved in the “currency of the future” may reap big benefits, particularly because the world is moving further into the digital realm, which will require more use of digital currencies.

MMTec (MTC), closed Friday's trading session at $2.56, up 96.9231%, on 74,528,526 volume. The average volume for the last 3 months is 928,242 and the stock's 52-week low/high is $0.3572/$4.86.

Cardiff Oncology (CRDF)

MarketClub Analysis, MarketBeat, InvestorPlace, The Online Investor, StockMarketWatch and QualityStocks reported earlier on Cardiff Oncology (CRDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cardiff Oncology Inc. (NASDAQ: CRDF) (FRA: XE7C) is a clinical stage biotechnology firm that is focused on the development of treatments and therapies for hematologic and solid tumor cancer.

The firm has its headquarters in San Diego, California and was incorporated in 1999 by Hovsep Melkonyan, Samuil Umansky, L. David Tomei and Gabriel M. Cerrone. Prior to its name change in May 2020, the firm was known as Trovagene Inc.

The company is party to a research collaboration with Nektar Therapeutics, which entails the development of a colorectal cancer treatment. Its clinical programs include mCRPC (Resistance Metastatic Castration-Resistant Prostate Cancer) and mCRC (KRAS-Mutated Metatstatic Colorectal Cancer). It mainly serves pharmaceutical firms in the state of California.

The enterprise’s product pipeline is made up of a polo-like kinase adenosine triphosphate competitive inhibitor dubbed onvansertib, which is currently undergoing a phase 1b/2 clinical trial evaluating its effectiveness in treating acute myeloid leukemia. The formulation recently concluded a phase 1b/2 clinical trial which assessed its efficacy in treating metastatic colorectal cancer in combination with Avastin and FOLFIRI and another phase 1 clinical trial which evaluated its efficacy in treating advanced solid tumors. This formulation is also undergoing a phase 2 clinical trial testing its effectiveness in treating metastatic castration-resistant prostate cancer, in combination with Zytiga.

The company has in the recent past highlighted the clinical benefits of its onvansertib formulation across various indications and advanced its drug development programs. It is now focused on expanding the aforementioned formulations pipeline of indications which, if successful, will positively influence the company’s growth.

Cardiff Oncology (CRDF), closed Friday's trading session at $2.91, up 64.8725%, on 45,135,566 volume. The average volume for the last 3 months is 3.872M and the stock's 52-week low/high is $0.94/$3.07.

Adial Pharmaceuticals (ADIL)

MarketClub Analysis, StockMarketWatch, QualityStocks, BUYINS.NET, TopPennyStockMovers, MarketBeat, TradersPro, The Online Investor, StreetInsider, Small Cap Firm, Schaeffer's, PoliticsAndMyPortfolio, PennyStockScholar, PennyStockProphet and 360wallstreet reported earlier on Adial Pharmaceuticals (ADIL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is a clinical-stage biopharmaceutical firm that is engaged in developing treatments for preventing or treating addiction and associated disorders.

The firm has its headquarters in Charlottesville, Virginia and was incorporated in November 2010 by Bankole A. Johnson. It operates as part of the pharmaceutical manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry and serves consumers in Virginia.

The enterprise’s pipeline is made of a selective serotonin-3 antagonist dubbed AD04, which is indicated for treating alcohol use disorder. The active ingredient in the formulation, i.e. ondansetron, is the serotonin-3 antagonist. The formulation has also been indicated for the treatment of other addictive disorders including smoking, obesity and opioid use disorder, among other drug addictions. The candidate recently concluded its phase 2b study which tested its effectiveness in treating alcohol use disorders, and it demonstrated promising results in decreasing the quantity and frequency of heavy drinking and drinking in general, with no noticeable safety concerns. The enterprise also develops AD01, which is indicated for treating addictive behaviors, and recently concluded phase 1 trials. In addition to this, the enterprise is also involved in the development of drug candidates for non-opioid pain alleviation and other disorders and ailments.

The firm is planning to venture into the genetic testing market after receiving a patent for its AD04 candidate, bringing the firm one step closer to helping identify patients that could benefit from their formulation. This move will also allow the firm to commercialize a companion diagnostic test to AD04 in the future, which will help extend its consumer reach and in turn, bring in even more investors.

Adial Pharmaceuticals (ADIL), closed Friday's trading session at $3.26, up 59.8039%, on 78,280,139 volume. The average volume for the last 3 months is 1.859M and the stock's 52-week low/high is $0.765/$15.00.

BioVie Inc. (BIVI)

RedChip, QualityStocks, TradersPro, MarketBeat, Zacks, Wealth Insider Alert, Trading Tips, The Stock Dork, Smart Investing Society, Red Chip, Prism MarketView, MarketClub Analysis and INO Market Report reported earlier on BioVie Inc. (BIVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioVie Inc. (NASDAQ: BIVI) is a clinical stage biotechnology firm that is engaged in discovering, developing and commercializing drug therapies, with a focus on liver disease.

The firm has its headquarters in Santa Monica, California and was incorporated in 2013, on April 10th. Prior to its name change in July 2016, the firm was known as NanoAntibiotics Inc. The firm serves consumers around the world.

The company is focused on developing transformative therapies that will meet significantly unmet medical needs for patients suffering from chronic debilitating conditions. Its initial disease targets are conditions which impact individuals across the globe.

The enterprise’s product portfolio comprises of an ERK inhibitor dubbed NE3107, which is in its pre-clinical stage and has been developed to treat prostate cancer and multiple myeloma. This formulation, which also selectively decreases insulin resistance and neuro-inflammation, is also undergoing a phase 1 clinical trial and a phase 3 clinical trial evaluating its effectiveness in treating Parkinson’s disease and Alzheimer’s disease respectively. It also develops BIV201, which has concluded its phase 2 clinical trial testing its efficacy in treating ascites due to chronic liver cirrhosis. This formulation is also a treatment option for patients with complications of advanced liver cirrhosis brought about by alcoholism, non-alcoholic steatohepatitis and hepatitis. BIV201 has an Orphan Drug designation for hepatorenal syndrome treatment.

The company recently began patient trials for its BIV201 candidate for Alzheimer’s, which shows promise as a potential treatment. The success of the company’s BIV201 formulation in treating this degenerative disease would not only meet the unmet needs of patients with this indication but also bring in more investors into the company, which would boost the company’s growth.

BioVie Inc. (BIVI), closed Friday's trading session at $1.89, up 52.4194%, on 92,685,744 volume. The average volume for the last 3 months is 18.54M and the stock's 52-week low/high is $0.8902/$11.3899.

Jaguar Health (JAGX)

QualityStocks, MarketBeat, BUYINS.NET, StockMarketWatch, StreetInsider, InvestorPlace, The Online Investor, StocksEarning, StockRockandRoll, Schaeffer's, PennyStockLocks, Penny Stock 101, 360wallstreet, DreamTeamNetwork, MarketClub Analysis, 247 Market News, Promotion Stock Secrets, Wealth Insider Alert, Stock Beast, The Stock Dork, Trades Of The Day and PoliticsAndMyPortfolio reported earlier on Jaguar Health (JAGX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jaguar Health Inc. (NASDAQ: JAGX) (FRA: 1JA2) is a commercial-stage pharmaceuticals firm that is focused on developing and commercializing gastrointestinal products for animals and human prescription use and non-prescription gastrointestinal animal products.

Jaguar Health has its headquarters in San Francisco, California and serves the human and animal health markets across the globe. The firm was established on June 6, 2013 by Lisa A. Conte.

Through its Napo Pharmaceuticals Inc. subsidiary, Jaguar Health Inc. develops and commercializes proprietary human gastrointestinal products. This is in addition to operating through 2 segments: Animal health segment and Human health segment. The former segment commercializes non-prescription and prescription products for production and companion animals while the latter segment develops human products and advertises one of the firm’s products called Mytesi which is used to provide symptomatic relief of non-infectious diarrhea in adults on ARV therapy for HIV/AIDS.

Jaguar Health Inc.’s human products include a crofelemer formulation which is currently undergoing a phase 2 clinical trial for the treatment of irritable bowel, functional/idiopathic diarrhea, congenital diarrheal disorder and short bowel syndrome; crofelemer, which is in its phase 3 clinical trials for supportive care for inflammatory bowel disease and treatment of diarrhea associated with cancer therapy. The firm’s animal products include Neonorm Foal and Neonorm Calf, as well as a non-prescription product for gut health in equine athletes known as Equilevia and an animal prescription drug candidate indicated for the treatment of diarrhea in dogs induced by chemotherapy, called Canalevia.

Jaguar Health Inc. recently incorporated its Napo EU subsidiary in anticipation of its merger with Italian Dragon SPAC, which will broaden the firm’s consumer base overseas and boost growth. The subsidiary will help address the increasing burden of inflammatory diarrhea that has been linked to long-hauler syndrome in the post-coronavirus patient population over in Europe.

Jaguar Health (JAGX), closed Friday's trading session at $0.0885, up 50%, on 303,339,477 volume. The average volume for the last 3 months is 239,077 and the stock's 52-week low/high is $0.0512/$1.92.

JanOne (JAN)

Broad Street, AwesomeStocks, StockMarketWatch, BUYINS.NET, QualityStocks, StockStreetWire, Small Cap Firm, TradersPro, StockWireNews, Fierce Analyst, MarketClub Analysis, MicroCapDaily, OTCtipReporter, Penny Stock 101, PennyStockLocks, PennyStockScholar, Schaeffer's, StockRockandRoll, StreetInsider, TopPennyStockMovers and PennyStockProphet reported earlier on JanOne (JAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

JanOne Inc. (NASDAQ: JAN) (FRA: 5AR1) is a clinical-stage biopharmaceutical firm that is engaged in the identification, acquisition, licensing, development and commercialization of new, non-addictive, non-opioid treatments that address previously unmet medical needs to treat pain.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in 1976 by Edward R. Cameron. Prior to its name change in September 2019, the firm was known as Appliance Recycling Centers of America Inc. It operates in the healthcare sector, under the biotech and pharma sub-industry and serves consumers in the United States.

The company operates in the Technology, Recycling and Biotechnology segments. Its recycling segment is engaged in the collection, recycling and installation of appliances for utilities and other consumers. It also focuses on the General Electric agreement. Its other segments are involved in selling appliance via Appliance Smart stores.

The enterprise’s product pipeline is made of a patented oral and sustained release pharmaceutical sodium nitrite composition which targets poor blood flow in patients suffering from peripheral artery disease and diabetes and is indicated for the treatment of pain. The enterprise also offers turnkey appliance replacement and recycling services for sponsors of efficiency programs. This is in addition to designing, developing and selling cellular transceiver modules and associated wireless services.

The firm recently appointed a world renowned expert on addiction to its advisory board and he brings with him decades of experience in drug addiction. This addition will be useful as the firm advances its treatment for PAD and will also be beneficial to their patients who will be utilizing their products.

JanOne (JAN), closed Friday's trading session at $1.595, up 46.3303%, on 1,204,085 volume. The average volume for the last 3 months is 18.803M and the stock's 52-week low/high is $0.2204/$1.725.

Meta Platforms Inc. (META)

The Street, Zacks, InvestorPlace, Investopedia, Early Bird, Schaeffer's, MarketClub Analysis, MarketBeat, The Online Investor, Kiplinger Today, INO Market Report, Cabot Wealth, Louis Navellier, TipRanks, The Night Owl, Top Pros' Top Picks, Money Wealth Matters, Trading Tips, The Daily Market Alert, TradersPro, AllPennyStocks, Eagle Financial Publications, Investment House, InvestorIntel, The Wealth Report, DividendStocks, Daily Wealth, Smartmoneytrading, Market Trends, CNBC Breaking News, Trading with Larry Benedict, FreeRealTime, Contrarian Outlook, Investing Daily, Jon Markman’s Pivotal Point, Smart Investing Society, The Stock Dork, bullseyeoptiontrading, Trade Out Loud, Rick Saddler,, Empire Financial Daily, wyatt research newsletter, The Investing Insider, TradingPub, 360 Wall Street, Chaikin Analytics, empirefinancialresearch, Hit and Run Candle Sticks, iDigital Market, Investor News, InsiderTrades, OTC Stock Review, Investing Breakout, The SmartMoneyTrading, Investor's Business Daily, 1 2 3 Trade Option, QualityStocks, Mind Over Markets and Inside Trading reported earlier on Meta Platforms Inc. (META), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

For the past couple of months, news cycles worldwide have been filled with stories of increasingly advanced and complex artificial intelligence (AI) tools that use machine learning to achieve incredible feats. However, while this technology will undoubtedly revolutionize industry in a myriad of ways, many experts are worried about the potential impact of AI-generated disinformation during election cycles.

Advancements in both software and hardware have allowed startups such as OpenAI and Stability AI as well as established tech companies such as Google and Microsoft to develop increasingly advanced generative AI models. Tools such as OpenAI’s ChatGPT, for instance, can generate pages of text based on short, concise user prompts, allowing individuals to create significantly more written content than they could without the tool.

Despite being mostly unregulated, artificial intelligence technology is becoming increasingly entrenched in American society. Deepfake technology (not AI) can already create false but convincing images, videos and even audio of well-known personalities such as celebrities and politicians. AI technology is significantly more advanced than deepfake technology and has the potential to flood the internet with misinformation, false data and even made-up information in a short time.

Just this year, an AI-generated robocall targeted voters in New Hampshire during the January primary, claimed to be President Joe Biden, and asked voters to stay at home. U.S. officials say this was the first time bad players attempted to use artificial intelligence to interfere with elections in the country. Although it still isn’t clear if the AI-powered deepfake calls had an actual effect on voter turnout, Public Citizen executive vice president Lisa Gilbert says the fact that AI is already being used to influence voters is enough for immediate action.

Public Citizen is a nonprofit consumer advocacy group that has been pushing for state and federal officials to regulate the use of artificial intelligence in politics. Gilbert notes that we shouldn’t wait to see how many people can be deceived by AI-powered tools such as the deepfake calls in New Hampshire.

CNN recently reported that fake audio recordings may have been used to sway elections in Slovakia, an indication that bad actors could potentially use AI to interfere with the 2024 presidential elections. The Federal Communications Commission banned AI-powered robocalls after the New Hampshire calls, but it still hasn’t ruled on the use of artificial intelligence in political ads.

A U.S. House bipartisan taskforce was recently tasked with researching different ways of regulating AI, but it is unclear if it could produce actionable results before the elections begin.

Major tech companies that are heavily involved in AI, such as Meta Platforms Inc. (NASDAQ: META), have plenty to do to ensure that these new technologies aren’t abused by elements with wrong intentions, especially during pivotal activities such as the upcoming U.S. elections.

Meta Platforms Inc. (META), closed Friday's trading session at $502.3, up 2.483%, on 15,884,882 volume. The average volume for the last 3 months is 1.634M and the stock's 52-week low/high is $171.43/$504.25.

Sidus Space Inc. (SIDU)

RedChip, MarketClub Analysis, QualityStocks, FreeRealTime, Wall St. Warrior, Money Wealth Matters, InsiderTrades and INO Market Report reported earlier on Sidus Space Inc. (SIDU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sidus Space (NASDAQ: SIDU), a multifaceted space and data-as-a-service company, has announced the pricing of an underwritten public offering of 1,321,000 shares of its Class A common stock, which is expected to close on Mar. 5, 2024. The announcement noted that each share of Class A common stock is being sold at a public offering price of $6.00 per share for gross proceeds of approximately $7.9 million before deducting underwriting discounts and offering expenses. The company intends to use the net proceeds from the offering for working capital and general corporate purposes. ThinkEquity is acting as sole book-running manager for the offering.

To view the full press release, visit

About Sidus Space Inc.

Sidus Space is a multifaceted space and data-as-a-service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support. The company is located in Cape Canaveral, Florida, where it operates from a 35,000-square-foot manufacturing, assembly, integration, and testing facility focused on vertically integrated space-as-a-service solutions including end-to-end satellite support. Sidus Space has a mission of Bringing Space Down to Earth(TM) and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. More than just a “Satellite-as-a-Service” provider, Sidus Space’s products and services are offered through its four business units: Space and Defense Hardware Manufacturing, Satellite Manufacturing and Payload Integration, Space-Based Data Solutions, and AI/ML Products and Services to support customers from concept to Low Earth Orbit and beyond. Sidus Space is ISO 9001:2015, AS9100 Rev. D certified, and ITAR registered.

Sidus Space Inc. (SIDU), closed Friday's trading session at $6.16, off by 31.4031%, on 3,201,284 volume. The average volume for the last 3 months is 906,036 and the stock's 52-week low/high is $3.2701/$104.00.

Curaleaf Holdings Inc. (CURLF)

InvestorPlace, Kiplinger Today, QualityStocks, MarketBeat, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, MarketClub Analysis, Profit Trends, The Online Investor, StreetInsider, Wealth Insider Alert, Early Bird, Trades Of The Day, Trading For Keeps, The Street, Investment U, Daily Profit, CFN Media Group, StreetAuthority Daily, Zacks, TradersPro, Wyatt Investment Research, wyatt research newsletter and Schaeffer's reported earlier on Curaleaf Holdings Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

At the moment, marijuana remains illegal at the federal level. This is despite the fact that 38 states have legalized its medical use while another 24 states legally allow recreational use. Marijuana advocates believe the Biden administration is missing out on a chance to attract young voters by not legalizing the drug federally.

Thus far, the administration has availed different avenues for cannabis reform, including initiating the process of possibly rescheduling the drug’s status and issuing federal pardons for simple possession. Advocates argue that this isn’t enough, however, noting that President Joe Biden is not addressing marijuana’s criminalization, which has disproportionately affected minorities. The president is also failing to live up to his 2020 campaign promise to decriminalize the use of marijuana and automatically expunge previous convictions.

Progressive legislators in the senate are calling for the administration to deschedule marijuana because this would decriminalize the drug at the federal level. This is much better than rescheduling marijuana, which would reduce restrictions and penalties by moving it from its current Schedule I classification under the Controlled Substances Act to Schedule III.

Last month, a group of Democratic legislators penned a letter to the U.S. Drug Enforcement Administration (DEA) stating that the placement of cannabis in the Controlled Substances Act didn’t align with public opinion or state law and had had a destructive impact on communities.

In a recent interview, Marijuana Policy Project’s director of state policies, Karen O’Keefe, stated that while rescheduling marijuana was better than existing categorization, it was still a far cry from what was needed from the federal government. Numerous polls have shown that a majority of the public is in favor of cannabis being legalized federally. One Gallup survey conducted last year determined that 70% of Americans believed that cannabis should be legal. Another recent survey also underscores public support for federal cannabis reform, with 58% of those polled in favor of the drug being rescheduled.

Currently, President Biden and his likely rival, former President Donald Trump, are polling side by side both in crucial swing states as well as nationally. It is expected that the election could boil down to a couple thousand voters in those states, which gives issues such as cannabis legalized added importance.

At the moment, the DEA hasn’t decided on cannabis’ rescheduling. Additionally, the pardons issued by the Biden administration in 2022 didn’t apply to convictions made at the state level, which means that there’s more work that needs to be done in that space as well.

The cannabis industry, together with leading actors such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), will have to keep operating within the existing regulatory framework as they await federal reforms that finally regard this industry like any other business.

Curaleaf Holdings Inc. (CURLF), closed Friday's trading session at $4.85, up 1.6771%, on 636,849 volume. The average volume for the last 3 months is 43.992M and the stock's 52-week low/high is $2.19/$5.80.

Fisker Inc. (FSR)

Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, MarketBeat, MarketClub Analysis, StockEarnings, The Street, Kiplinger Today, The Online Investor, Early Bird, Daily Trade Alert, GreenCarStocks, Trades Of The Day, Money Wealth Matters, TradersPro, Investopedia, 360 Wall Street, The Night Owl, wyatt research newsletter, Louis Navellier, InsiderTrades, INO Market Report, TipRanks, DividendStocks, StreetInsider, CNBC Breaking News, Cabot Wealth and InvestorsUnderground reported earlier on Fisker Inc. (FSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

U.S.-Cuba diplomatic relations took a step forward recently when Texas-based carmaker Tesla exported the first American electric vehicle to Cuba. The arrival of the white Model Y at the Mariel Port dock in Cuba represents a historic moment in the auto industry as well as U.S.-Cuba relations and international trade.

With Cuba finally turning away from Venezuelan oil imports, the Cuban government is keen on increasing the country’s solar capacity. This month, the University of Maryland Global Campus (UMGC) will stream a film titled “Driving Towards Change” as part of its African-American History Month activities. The film will feature sequences of the Tesla Model Y traveling from Jacksonville, Florida, to Mariel Port in Cuba. These sequences were not included when the original film premiered Maryland and at a Cuban event.

John Felder, a (UMGC) alumnus who partnered with New Jersey’s Advanced Solar Products to install dozens of public EV-charging stations in Cuba, was mostly responsible for the historic feat. Felder is a long-time proponent of vehicular electrification and believes both EVs and solar energy have significant potential for growth in the Caribbean. A self-described “gearhead,” Felder already had authorization to import electric scooters into Cuba but says that it wasn’t easy obtaining authorization to export directly from the United States to Cuba. He reportedly spent a whopping 15 years negotiating with U.S. and Cuban government officials while working out the logistics of exporting vehicles to Cuba and remaining profitable.

Felder acknowledges that operating in Cuba is difficult, especially for American companies whose activities are curtailed by the embargo. Obtaining permission to export an EV from the U.S. to the island of Cuba required that he forge an agreement between two adversaries, he says. Ultimately, Felder had to meet certain conditions before he could export a Tesla to Cuba. For starters, only private citizens would be potential customers and the EVs would never be resold to Cuba’s government. For this first export, the buyers were a couple who owned a Cuban restaurant in Maryland and also had family property in Cuba.

Felder was also instrumental in getting the first Nissan Leaf past the embargo and into Havana’s Embassy of Guyana in 2017. The deal was thanks to a limited four-year license from the Bureau of Industry and Security at the U.S. Department of Commerce with aid from Premier Automotive Export’s Cayman Islands subsidiary.

The limited license only allowed Felder to sell to embassies in Cuba. He is now negotiating the sale of a Tesla to the Egypt Embassy in Cuba. If the deal is successful, a Premier Automotive Export technician can travel to Cuba to handle maintenance and repairs.

The ingenuity and tenacity that Felder exhibited in pulling off the EV export to Cuba is a skill that would come in handy for EV makers across the board, including entities such as Fisker Inc. (NYSE: FSR), especially given the growing competition that could push some manufacturers out of the market in the decades to come.

Fisker Inc. (FSR), closed Friday's trading session at $0.4825, off by 33.7407%, on 369,944,141 volume. The average volume for the last 3 months is 12.152M and the stock's 52-week low/high is $0.377/$7.765.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Schaeffer's, Kiplinger Today, MarketBeat, StocksEarning, The Online Investor, Investopedia, Market Report, Barchart, StreetAuthority Daily, Daily Trade Alert, Top Pros' Top Picks, TopStockAnalysts, StreetInsider, QualityStocks, Louis Navellier, Streetwise Reports, Daily Wealth, SmarTrend Newsletters, Zacks, Uncommon Wisdom, TradingMarkets, Money Morning,, PROFIT CONFIDENTIAL, Trades Of The Day, Wealth Daily, The Growth Stock Wire, TheStockAdvisor, The Wealth Report,, ProfitableTrading, Wall Street Grand, StockEarnings, Cabot Wealth, Trading Tips, Investing Signal, Market Intelligence Center Alert, Dividend Opportunities, TheStockAdvisors, The Best Newsletters, InvestorIntel, National Inflation Association, DividendStocks, Trading Markets, All about trends, AllPennyStocks, Market FN, Wyatt Investment Research, Energy and Capital, InvestmentHouse, MiningNewsWire, Stockhouse, Money and Markets, Darwin Investing Network, Buttonwood Research, TradingAuthority Daily, Wall Street Daily, InvestorsObserver Team, Daily Markets, Investment House, OTC Stock Pick, Street Insider, Investors Alley, Investiv, Money Wealth Matters, Wall Street Greek, Dynamic Wealth Report, StreetAlerts, The Tycoon Report, Early Bird, Eagle Financial Publications, FNNO Newsletters, Short Term Wealth, Wealth Insider Alert, Daily Profit, Market Authority, Investing Futures, The Stock Enthusiast,, Trading Concepts, Trader Jack, MarketWatch, StockTwits, Investment U, 24/7 Trader, Investor News, Investing Daily, Candle Stick Forum, Insider Wealth Alert, INO Market Report, CNBC Breaking News, equities Canada, Global Equity Alert, ChartAdvisor, Global Equity Report,, Total Wealth, SmallCap Network, Super Stock Picker, The Motley Fool, The Street Report, The Wall Street Transcript, Normandy Investment Research, TipRanks, Rick Saddler, Trade of the Week, UndiscoveredEquities, Vantage Wire, VectorVest, Wall Street Window, Weekly Wizards, The Weekly Options Trader, Penny Detectives, Investor Update, Investors Insights, Jim Cramer, Leeb's Market Forecast, MarketClub, Navellier Growth, Small Cap Firm, OTCPicks, Seeking Alpha, Penny Stock Buzz, PennyStockProphet, Power Profit Trades, Profitable Trader Authority, Profits Run, Investor Guide and One Hot Stock reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Canadian miner Fury Gold Mines has purchased Newmont Corporation (NYSE: NEM)’s nearly 50% stake in the Quebec-based Éléonore South project for $2.2 million. The high-grade gold exploration company will spend an additional $960,000 on the acquisition of around 30.4 million Sirios Resources shares held by Newmont as part of Éléonore South’s consolidation.

Fury said the acquisition of Sirios shares was for investment purposes and that the company would continually evaluate the investment to determine the feasibility of any additional dispositions or purchases.

Newmont recently announced that it was planning to divest six of its noncore properties, including the Yukon Territory-based Coffee Project; the Ontario-based Porcupine and Musselwhite mines; its 70 percent stake in Haveiron, a Western Australia jointly owned asset with its partner Greatland Gold; and the Éléonore South project in Quebec. The Éléonore South project is located in a region with significant gold mineralization — Sirios’ Cheechoo deposit is in the east and Newmont’s Éléonore mine is in the north.

Fury Gold Mines CEO Tim Clark said the company values its “strong relationship” with Newmont and was confident of the partnership leading to positive outcomes for both organizations. He said the Éléonore South Joint Venture (ESJV) currently ranks as a leading prolific mineral discovery targets.

In a news release issued after Fury Gold acquired Newmont’s 49.978% stake in the Éléonore South project, Clark said the Canadian miner is excited to have 100% ownership because it will open up the way for wider exploration and increase Fury’s chances of getting a greater return on investment.

According to Fury Gold, prospecting efforts have uncovered two different mineralization styles within the project: intrusion-related disseminated gold mineralization and structurally controlled veins of quartz. The former was comparable to the top-grade deposits within the Éléonore asset while the latter is similar to low-grade ore extracted from the Cheechoo deposit.

Fury Gold said that the project still has plenty of unexplored gold in-till anomalies with near-identical characteristics as those in the mineralization exhibited by the Cheechoo; the company also noted that dealing with these anomalies would be one of its major objectives. With more than 4.5 million ounces of gold estimated to surround the ESJV project, it has significant exploration potential.

Bryan Atkinson, SVP of exploration at Fury Gold Mines, says the team is excited to leverage its “systematic and disciplined exploration approach” to take advantage of the gold anomalies at the  Éléonore South project.

Newmont Corporation (NEM), closed Friday's trading session at $31.94, up 2.208%, on 17,018,707 volume. The average volume for the last 3 months is 31.216M and the stock's 52-week low/high is $29.42/$52.76.

Riot Platforms (RIOT)

Schaeffer's, MarketClub Analysis, InvestorPlace, StocksEarning, QualityStocks, StockMarketWatch, INO Market Report, MarketBeat, Zacks, TradersPro, Market Intelligence Center Alert, The Street, The Online Investor, StockEarnings, Early Bird, Kiplinger Today, TraderPower, InvestorsUnderground, AllPennyStocks, BUYINS.NET, Trades Of The Day, Investment House, Daily Trade Alert, PennyStockLocks, Market Intelligence Center, BillionDollarClub, StockRockandRoll, Trading Tips, The Wealth Report, StreetAuthority Daily, MarketMovingTrends, Penny Stock 101, ProsperityPub, Investors Alley, Jeff Clark Research, Promotion Stock Secrets, Money Morning, The Daily Market Alert, DividendStocks, Louis Navellier, CryptoCurrencyWire, TopPennyStockMovers and StreetInsider reported earlier on Riot Platforms (RIOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin mining giant Riot Platforms (NASDAQ: RIOT) recently published a report outlining the potential risks of being exposed to cryptocurrency companies plagued with instability. With several cryptocurrency platforms collapsing in recent years, distrust in the nascent crypto sector is at an all-time high.

According to Riot’s latest annual report, several risks have the potential to impact the company and disrupt its Bitcoin mining operations. These include a potential reduction in on-chain transition fees, problems in the wider cryptocurrency economy and an anticipated Bitcoin halving event in April. According to Riot, the halving event is particularly risky because it can potentially reduce mining rewards as a top concern for achieving profitability in the future.

Several collapses within the crypto sector have increased distrust in digital currencies such as Bitcoin, led to more regulatory scrutiny of cryptocurrencies and resulted in a significant reduction in Bitcoin’s value. Riot’s yearly report noted that the April 2020 bitcoin halving, a process that cuts block rewards by 50%, could threaten the Bitcoin miner’s profitability as well as its ability to attract data center clients at the institutional level.

Even though historical data shows that prices tend to go up during Bitcoin halvings, Riot Platforms says there’s no guarantee that the upcoming halving, as well as future halvings, will have enough of a positive impact on Bitcoin prices to make up for the loss of 50% of mining rewards.

Riot cautions that if future Bitcoin halving events aren’t accompanied by a proportionate and corresponding increase in Bitcoin prices, its Bitcoin mining revenue will drop. The result would be a notable negative effect on the results of Riot’s bitcoin mining efforts and its overall financial condition, the Bitcoin miner says.

April’s Bitcoin halving will be the fourth halving event since the cryptocurrency launched. Over the years, prior halving events have consistently reduced Bitcoin mining rewards as miners increasingly see on-chain transaction fees as a critical incentive. Unfortunately, an increase in fees may lower Bitcoin’s appeal as a payment option and could even contribute to a drop in Bitcoin demand and prices. Riot notes that a fall in Bitcoin demand could cause future Bitcoin prices to drop as well, ultimately resulting in a material and adverse impact on its securities.

Additionally, the Bitcoin miner said that it will have to work on mitigating issues such as slow transaction settlements and high Bitcoin fees because they have the potential to hinder the wider adoption of the cryptocurrency.

Riot Platforms (RIOT), closed Friday's trading session at $14.44, up 2.2663%, on 22,850,908 volume. The average volume for the last 3 months is 42,796 and the stock's 52-week low/high is $5.16/$20.65.

The QualityStocks Company Corner

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

Artificial Intelligence ("AI") has become an increasingly prominent tool in the battle against climate change

AI can now be used across a myriad of use cases, ranging from tracking small-scale deforestation through to measuring the melting rate of the polar icecaps

Turbo Energy has looked to harness AI technologies within its core product portfolio, including its SunBox and GoSolar home energy systems

AI has emerged as a key tool within solar energy management systems, driving efficiency and lowering costs across the solar energy production supply chain

Home to over 5 million square kilometers of tropical rainforest and storing over 200 petagrams (1 petagram = 1 billion tons) of carbon, the Amazon Basin ranks amongst the world's most important ecosystems with direct implications for both, regional and global climate. Nevertheless, and until recently, authorities were unable to track the rise of small-scale deforestation taking place across significant swathes of the Amazon rainforest. Forest loss within the Amazonia has been monitored by the Brazilian Institute for Space Research ("INPE") since 1988; however, INPE studies are woefully limited in scope. The research agency's focus has historically been confined to the Brazilian Amazon, with its technology solely able to track disturbances greater than 6.25 hectares in area (equivalent to approximately 8 football fields) ( Now, and capitalizing on the technological advances offered by artificial intelligence, companies such as Scotland-based Space Intelligence are able to remotely map millions of hectares of land from space using satellite data, with the company's innovative technology able to track metrics such as ongoing deforestation rates or calculate the carbon storage content within a forest ( Turbo Energy (NASDAQ: TURB), a designer, developer and manufacturer of photovoltaic energy generation, management, and storage equipment has emerged as a pioneer in harnessing AI within its solar energy solutions.

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.


Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.


The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Friday's trading session at $1.23, up 2.5%, on 2,461 volume. The average volume for the last 3 months is 3,559 and the stock's 52-week low/high is $0.855/$7.90.

Recent News

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Astrotech (NASDAQ: ASTC) is a mass spectrometry company that, through its wholly owned subsidiary 1st Detect, has developed and rolled out the breakthrough TRACER 1000(TM) Explosive Trace Detector ("ETD"). "The world's first mass spectrometry-based ETD certified by the European Civil Aviation Conference (‘ECAC'), the TRACER 1000(TM) is designed to outperform the ETDs currently used at aviation checkpoints as well as borders, cargo facilities and other secured points around the world. It is powered by the Astrotech Mass Spectrometer (‘AMS') Technology that is inexpensive, smaller and easier to use when compared to traditional mass spectrometers. The AMS Technology works under ultra-high vacuum, which eliminates competing molecules, resulting in higher resolution and fewer false alarms," a recent article reads. "Astrotech nonetheless believes that ETD customers are unsatisfied with the currently deployed ETD technology, which is driven by ion mobility spectrometry (‘IMS')… Against this backdrop and as many of the tens of thousands of IMS instruments deployed in the field near their end of life and need replacement, Astrotech is working to position its TRACER 1000(TM) product as the next-generation solution for the ETD market. ‘Based on our near-zero false alarm rate, we believe that the TRACER 1000(TM) improves checkpoint efficiency and passenger throughput by reducing the need for time-consuming and invasive secondary screenings that cost airports millions in lost merchandise and food sales,' said Thomas B. Pickens III, chairman and CEO of 1st Detect."

To view the full article, visit

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.


Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Friday's trading session at $8.1922, up 1.1383%, on 4,502 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.90/$.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities, is one of the companies committed to providing robust and stable benefit offerings to a growing number of people looking for the best Medicare options. "In a space where a growing number of individuals are qualifying for Medicare, Astiva Health is differentiating itself as a fast-growing Medicare Advantage Prescription Drug (‘MAPD') health plan focused on redefining the standards of personalized and comprehensive healthcare. As an indication of its success, Astiva recently reached a key milestone, surpassing the 10,000-member mark… Reaching the milestone – a substantial increase from Astiva's 4,700 members in September 2023 – came in part from the company's strategic expansion into the California counties of Los Angeles, Riverside and San Bernardino. According to the company, the expansion, which went into effect on Jan. 1, 2024, marks a pivotal moment in Astiva Health's mission to reshape healthcare delivery and increase access to quality healthcare for a diverse range of individuals in Southern California," a recent article reads. "Astiva is working to achieve its goal of redefining the standards of personalized and comprehensive healthcare by focusing on improving member services, comprehensive medical care, prescription drugs, and great supplemental benefits."

To view the full article, visit

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News


PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica (NASDAQ: PXMD) is a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies ("APTs") for the treatment of autism spectrum disorder ("ASD") and other serious conditions with intractable neurologic symptoms. The company is on a promising path to address unmet medical needs of ASD patients. "The prevalence of ASD in the United States has risen to approximately 1 in 36 children, according to the Centers for Disease Control and Prevention (‘CDC'). There are currently no approved pharmacologic treatments that target the causes and symptoms of ASD – the treatment available on the market addresses symptoms of the condition rather than targeting the pathophysiology itself," a recent article explains. "PaxMedica intends to continue into 2024 with the momentum it has gained with its achievements during the past year. The company is building a robust product pipeline to allow people with ASD to successfully integrate their behavior with others and improve their lives. Its lead programs, PAX-101 and PAX-102, utilize the company's proprietary source of suramin sodium, a broadly acting APT known for over 100 years."

To view the full article, visit

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Friday's trading session at $0.65, up 3.1746%, on 47,900 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.372/$48.45.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

The potential economic impacts of transitioning to renewable energy such as solar and wind have left many questioning the financial feasibility of clean energy. With extreme weather events becoming increasingly common worldwide, the need for concrete climate-change remediation efforts is becoming more urgent. Research by Toronto Metropolitan University associate professor of global management studies Deborah de Lange suggests that renewable energy innovations have a positive impact on the economy. The professor found that transitioning to clean energy can contribute to a higher national GDP. The fossil-fuel industry affects consumer welfare negatively by keeping prices higher than necessary, de Lange says, leading to inflated profits which push GDP up. She says that implementing pollution taxes and supporting energy innovation is the most effective way of cutting carbon emissions while ensuring economic prosperity. The solutions that enterprises such as Correlate Energy Corp. (OTCQB: CIPI) offer geared at making it easier to get renewable power onto energy grids can be a viable way to integrate green energy into current energy mixes while easing away from dirty fuels.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Friday's trading session at $1.5, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3501/$2.35.

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company focused on building, acquiring, marketing, and operating assets through its wholly owned affiliates. The company is looking to tap into the strength of the high-end real estate market in the Hamptons. "Despite a high interest rate environment, Hamptons-based real estate has shown remarkable resilience over the past year… Despite seeing a 26% decline in year-over-year sales of individual properties, homes priced between $1 million and $3.5 million – which have historically accounted for the lion share of Hamptons' property transactions, only witnessed a 21% decline," a recent article reads. "Through its Mountain Top Capital Fund I, Mountain Top Realty has sought to raise $75 million to acquire, renovate and remarket homes in the Hamptons; in recent weeks, the company has revealed plans to conduct a Regulation A offering, which will seek to raise up to $10 million in gross proceeds, destined to be deployed in support of the company's real estate development plans. This will come on top of the fund's existing debt capital foray, which has seen the fund receive commitments amounting to 70% of their anticipated real estate acquisition costs as well as a further 100% of the planned construction costs, a figure which the company will seek to complement with the upcoming equity raising exercise. Mountain Top Realty will partner with On Site Builder Construction Co. Inc., as the design partner in its ambitious Hamptons-focused endeavor."

To view the full article, visit

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.


The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Friday's trading session at $0.058, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0085/$0.1898.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the U.S. Food and Drug Administration ("FDA") has confirmed the effectiveness of the company's investigational new drug ("IND") application thereby clearing Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. According to the announcement, the company is pleased to have complied with the FDA's rules and procedures for clearance to perform this important registrational trial. The company will further announce when it is ready to begin the study, subject to certain conditions, including raising sufficient funding. "This is a significant milestone achievement for Lexaria demonstrating, for the first time, that its DehydraTECH technology meets the FDA's high level of regulatory scrutiny sufficient to formally commence U.S. registrational clinical testing towards possible future pharmaceutical commercialization," said John Docherty, president of Lexaria. "We look forward to commencing this important clinical trial and building upon the wealth of early stage clinical data we have gathered and presented to the FDA to date demonstrating the safety, efficacy and novel mechanistic performance of DehydraTECH-CBD in hypertensive patients."

To view the full press release, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Friday's trading session at $2.92, off by 15.3623%, on 1,612,584 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6488/$3.5953.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES), an animal pest control innovator, created its own unique niche within the pest control market after introducing its non-lethal liquid ContraPest(R) bait. "Instead of poisoning rats, the bait targets fertility reduction in male and female rats, and Evolve(TM) has a similar mechanism of action but in a soft bait presentation preferred over liquids by pest management professionals (‘PMPs') and residential customers. SenesTech's products are the first, and still the only, such rat contraceptives for both males and females registered with the U.S. Environmental Protection Agency (‘EPA') designed to be non-lethal," a recent article explains. "The company conducted studies of ContraPest's effectiveness at poultry farms on the east and west coasts of the United States, through the farms' integrated pest management programs. The studies showed that SenesTech's product cut the rat population in half in three months and produced a sustained 90% reduction over the 12-month study at the western facility, and that pullet survival from predation rebounded by 88% at the eastern facility – delivering hundreds of thousands of dollars in benefits in the process."

To view the full article, visit

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.


SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Friday's trading session at $0.891, off by 0.944969%, on 127,289 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.52/$29.04.

Recent News

Vision Marine Technologies Inc. (NASDAQ: VMAR)

The QualityStocks Daily Newsletter would like to spotlight Vision Marine Technologies Inc. (NASDAQ: VMAR).

Vision Marine Technologies Inc. (NASDAQ: VMAR), a trailblazer in electric recreational boating, today announced Raffi Sossoyan as its new chief financial officer ("CFO"). Sossoyan brings a wealth of experience, with over 25 years in global financial and operational leadership. In his recent role as VP, corporate treasury at Velan Inc. (TSX: VLN), a Canadian multinational company, he managed financial operations amidst global sales exceeding US$370 million. According to the announcement, Sossoyan's tenure as CFO at Valtech Fabrication Inc., where he drove worldwide sales beyond US$50 million, further highlights his capacity to spearhead financial growth and success. "This strategic appointment marks a significant step as Vision Marine gears up for an ambitious phase focused on manufacturing, production and delivery, underlining the company's dedication to scaling its operations and enhancing its market footprint," the announcement noted. "With the appointment of Raffi Sossoyan as CFO, Vision Marine Technologies is poised to navigate its next phase of growth with enhanced financial acumen and strategic direction."

To view the full press release, visit

Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the performance electric recreational boating industry. The company is engaged in designing and manufacturing electric outboard powertrain systems and related technology. It strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment.

Vision Marine manufactures hand-crafted, highly durable, low maintenance, environmentally friendly electric recreational powerboats. The company’s business segments include the sale and rental of electric boats, with the majority of its revenue attributable to electric boat sales.

The designs and technology applied to Vision Marine’s boats result in enhanced performance, higher speeds and longer range. Put simply, Vision Marine boats offer a smoother ride than a traditional internal combustion engine motorboat.

The company is headquartered in Montreal.


Vision Marine’s flagship E-Motion™ 180E electric marine powertrain is the first fully electric outboard powertrain combining advanced battery pack, inverter and high efficiency motor with proprietary union assembly between the transmission and motor. Vision Marine’s E-Motion and related technologies in this system utilize extensive control software and are uniquely designed to improve the efficiency of the outboard powertrain. As a result, both range and performance are enhanced.

More than a powerful electric outboard motor, the 180E is a complete powertrain package. The high-tech, marine-specific motor is equipped with multi-sensor captors and independent cooling, providing 180 horsepower.

An onboard charging system allows for quick and easy charging from any shore outlet, whether the vessel is in or out of the water. It implements cutting-edge marine battery packs that are IP67 certified and built to withstand the harshest marine environments. The system is glycol cooled with a controlled heat exchanger, ensuring optimal performance and longevity. A stainless-steel casing protects the battery from corrosion and physical damage over time.

The 180E is built to be integrated with many boat models produced by other marine manufacturers. Since boat manufacturers rarely build their own engines, instead choosing to source them from engine manufacturers, Vision Marine believes the 180E propulsion system can in the future end up powering nearly every recreational boat.

Market Opportunity

According to a report from Future Market Insights, a certified market research organization, the global electric boats market is expected to grow from a value of $5.6 billion in 2023 to $15.1 billion by 2033, achieving a CAGR of 10.4% during the forecast period.

Factors driving growth include rising seaborne commerce activities, a flourishing marine tourism industry and stringent emissions regulations aimed at reducing pollution. In addition, government support for electric speedboat adoption, advances in technological development and research and forecast expansion of needed charging infrastructure are credited as growth drivers.

An emphasis on reducing carbon emissions and encouraging consumer adoption of eco-friendly boats is also likely to drive expansion of the market, the report states.

Management Team

Alexandre Mongeon is Co-Founder and CEO of Vision Marine Technologies. He has served as CEO since 2014. Prior to that, he imported high-performance boats from the United States to Canada for more than 15 years. During much of that time, he also worked as a designer and contractor and managed several new construction projects on the waterfront in and around Montreal. He is a graduate of the School of Construction in Laval, Quebec, with a specialization in electrical systems.

Xavier Montagne is Chief Technical Officer at Vision Marine. Prior to joining the company, he was the CEO of Mac Engineering for six years. While there, he was the electric powerline architect of the Renault Trezor concept car (awarded 2016 Best Concept Car), technical designer of the Zoe E-sport race car driven in Formula-E races from 2016-2019 and senior battery designer for Forsee Power, SAFT, Renault and Peugeot in Europe, to mention a few of the many projects he headed. He received an electronic engineer diploma from IFITEP Paris Polytech in France.

Kulwant Sandher is CFO at Vision Marine. He is a Chartered Professional Accountant with more than 25 years of experience in business and finance. He has served as CFO of multiple public and private companies, including ElectraMeccanica Vehicles Corp., MineSense Technologies Inc., Alba Mineral Ltd., Delta Oil & Gas, Astorius Resources Ltd., Norsemont Mining Inc. and Intigold Mines Ltd. He graduated from Queen Mary College, University of London.

Vision Marine Technologies Inc. (NASDAQ: VMAR), closed Friday's trading session at $0.780001, off by 1.2657%, on 91,615 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.69/$5.60.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom, a global leading provider of traditional and digital identity solutions, is pushing its EM solutions, specifically in the field of preventing domestic violence

Its products and services have so far been adopted by various governments and institutions around the world, among them two recent new clients in North America

According to Ordan Trabelsi, SuperCom's President and CEO, this is a testament to the undeniable effectiveness and reliability of the company's solutions

SuperCom (NASDAQ: SPCB), a global leading provider of traditional and digital identity solutions offering advanced identification and security products and solutions to governments, has, since 1988, been a trailblazer and leader in its space. So far, it has carved out a significant market share globally, and this all stems from a deep understanding of the problems on the ground and offering sustainable and practical solutions that have proven, time and time again, to work.

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More



In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.


Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Friday's trading session at $0.171, off by 0.058445%, on 503,688 volume. The average volume for the last 3 months is 1.825M and the stock's 52-week low/high is $0.16/$1.9399.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

After decades of frenzied debate about whether corporations should serve society or their shareholders, a historic United Nations ("UN") paper published in the early 2000s first used the term ESG to refer to Environmental, Social and Governance considerations. Titled "Who Cares Wins," the report outlined the need for sustainable developments by corporations and highlighted the critical role ESG considerations would play in ensuring the future of humanity and civilized society. Unsurprisingly, the environmental pillar is simultaneously the most critical and challenging consideration to address. Over a century of burning fossil fuels has resulted in significant damage to the atmosphere, throwing the planet out of its natural cycle of heating and cooling, and resulting in human-caused climate change. The U.S. Securities and Exchange Commission ("SEC") recently proposed regulations to standardize and enhance climate-related company disclosures, opening the door to the creation of standardized matrices for ESG rating agencies worldwide. As corporations await those standardized reporting requirements, some entities such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) are, of their own volition, implementing ESG practices in their operations because these practices are not only good for the environment and the people but they also deliver bottom-line benefits too.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.


Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Friday's trading session at $0.12, off by 6.6148%, on 16,210 volume. The average volume for the last 3 months is 23,498 and the stock's 52-week low/high is $0.0648/$0.765.

Recent News

Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF)

The QualityStocks Daily Newsletter would like to spotlight Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) .

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) is a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in Western Canada. The company uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery.

Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir development methods and production practices. It is in the midst of a three-stage restructuring process aimed at prioritizing cost effective operations while appreciating production capacity and reducing liabilities.

The company is based in Calgary, Alberta, Canada.


Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8% of total reserves having been recovered via legacy vertical well technology.

Restructuring Initiative

In 2021, Prospera enacted a top-down reorganization. The early results of these efforts were on display in May 2023, when the company reported a three-fold year-over-year increase in annual revenue for 2022 alongside drastically reduced operating costs and record-high cash flow from operations.

Prospera noted in the news release that it has positioned itself in 2023 to execute the second phase of its development plan aimed at increasing production through medium-oil development in Alberta and leveraging horizontal wells to capture the significant remaining reserves in Saskatchewan.

During the company’s investor summit in August 2023, Prospera CEO Samuel David provided more information regarding this three-phase strategy:

Phase I

Prospera completed the first phase of its restructuring by optimizing operations at its existing assets and addressing legacy arrears and non-compliance issues.

At the beginning of this transformation, the company was producing just 80 barrels of oil equivalent (BOE) per day. In Q4 of last year, Prospera peaked at nearly 1,200 BOE per day. Its breakeven is around 500 barrels per day, illustrating the opportunity for free cash flow. This prospect has driven Prospera’s capital development and optimization in recent quarters.

After a temporary slowdown in production due to harsh winter conditions, Prospera is currently producing about 800 BOE per day and anticipates an additional 300-500 barrels of daily production following the completion of ongoing site maintenance work.

This sustained increase has pushed the company’s NPV from roughly $3 million prior to the restructuring efforts to approximately $72 million today.

In an effort to build on this progress and maximize its available resources, Prospera piloted two horizontal reentries to assess a potential horizontal well transformation at its properties.

Phase II

Following up on the optimization efforts of Phase I, Prospera aims to commence a horizontal well transformation at its properties in the coming months. Based on its pilot wells from Phase I, the company has proposed 10 horizontal well locations at its Cuthbert and Heart Hills properties.

Prospera has likewise proposed eight medium light oil direction wells at its Alberta property, and it is exploring strategic acquisitions aimed at expanding its core area and diversifying its product mix.

Other facets of Phase II include piloting an enhanced oil recovery (EOR) application and continuing to execute its liability management goals and ESG initiatives. Prospera has already abandoned 60 vertical wells as part of its three-year LMR plan to reclaim surface land and reduce the environmental footprint of its operations.

Phase III

Beginning next year, Phase III of Prospera’s corporate redevelopment strategy will focus on continuing the company’s horizontal modular development to appreciate production and optimize recovery of remaining reserves. Prospera intends to implement full-scale EOR applications based on the results of its Phase II pilot program, which is forecast to optimize recovery by greater than 10%.

Prospera also intends to continue its acquisition strategy to diversify its product mix. Its goal, as detailed by in August 2023 investor summit, is to attain 50% light oil, 40% heavy oil and 10% gas – all while continuing to eliminate carbon emissions as part of its existing ESG initiatives.

Poised for Growth

Following its transformational efforts in 2022, Prospera is poised to achieve record growth in 2023. The company has forecast significant reductions in production costs through 2024, alongside sizable increases in daily production.

Prospera is currently exploring strategic acquisition targets to potentially increase its production beyond 5,000 BPD while expanding its reserve base to a billion barrels.

Market Opportunity

While the oil and gas industry faces long-term geopolitical and macroeconomic uncertainty, there is a clear trend to secure supply in the short term. According to Deloitte, the global upstream industry ended 2022 with some of the highest free cash flows on record, driving reinvestment in hydrocarbons and overall investment in clean energy.

The Energy Information Administration recently forecast a dip in global oil inventories over each of the next five quarters, placing upward pressure on oil prices. The agency further forecasts a YoY increase in fuel consumption, exacerbating the effects of OPEC+ production cuts that are set to remain in place through 2024.

For Prospera, these forecasts are promising. The company aims to build on its recent financial growth in the coming months (Prospera reported a three-fold YoY increase in revenue to $13.9 million in 2022), hitting a projected $57 million in total revenue by the end of 2024 while working to expand its core area holdings through accretive M&A transactions.

Leadership Team

Prospera is led by a team with extensive, diverse petroleum industry experience spanning both reservoir management and operations of oil and gas assets. The team boasts a proven track record of reorganizing companies, structuring financing arrangements and positioning for growth.

Samuel David is the company’s President and CEO. He brings to Prospera over 32 years of experience in operation, development and management of oil and gas assets and companies. Mr. David holds a B.Sc. in Mechanical Engineering and a B.A. in Economics from the University of Calgary. His background consists of both engineering and executive management experience with majors Petro-Canada, AEC Oil & Gas (now EnCana / Cenovus) and Husky Energy, as well as founding and operating juniors Ventura Energy and First West Petroleum. Mr. David has proven expertise in corporate planning, production, reservoir engineering, depletion strategies, EOR, property evaluations, acquisitions and divestitures.

George Magarian is VP Subsurface for Prospera. He is a professional petroleum geologist (APEGA) with over 36 years’ experience in the Western Canada Sedimentary Basin. After graduating with an Honors B.Sc. degree in Earth Science from the University of Waterloo, Mr. Magarian spearheaded many successful exploration programs, conducted evaluations for improved recovery schemes and assessed/exploited unconventional oil reservoir opportunities. He has held roles of increasing responsibility, from exploration geologist at oil industry major Petro-Canada and intermediates Anderson Exploration and Jordan Petroleum, to geoscience manager and VP exploration at junior companies Ionic Energy, Gentry Resources and Westfire Energy.

Chris Ludtke is the company’s VP Finance & Accounting. He is a high functioning finance leader with extensive expertise in finance, budgets and planning, accounting, economic evaluation, management, governance and sound decision making. Mr. Ludtke has 20 years of experience within the oil and gas, clean energy and renewables industries, including 12+ years working for Husky Energy before moving into an executive role in the junior oil and gas and hydrogen space. He graduated from the University of Lethbridge (Bachelor of Management) and is a Chartered Professional Accountant in the Province of Alberta.

Matthew Kenna is the CFO of Prospera. He has over 30 years’ experience leading organizations and helping them expand, drive efficiencies and grow profitability. Mr. Kenna is a professional accountant (CPA, CMA) and spent 15 years heading up the financial and operating departments at KUDU Industries, where he fostered financing arrangements, client relationships and manufacturing teams to take the organization from $35M to $150M in revenue. He has extensive experience turning companies around, growing them and building efficient organizations.

Prospera Energy Inc. (OTC: GXRFF), closed Friday's trading session at $0.0649, up 10.1868%, on 21,500 volume. The average volume for the last 3 months is 143,676 and the stock's 52-week low/high is $0.0485/$0.1194.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.